XML 60 R35.htm IDEA: XBRL DOCUMENT
v3.25.1

STOCKHOLDERS’ EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2024
Equity [Abstract] |
Schedule of assumptions for options granted |
Schedule of assumptions for options granted |  |  |  |  |  |  |  |
|  | Year ended December 31, |
|  | 2024 |  |  | 2023 |
Expected volatility |  |  | 89.04% - 92.70% |  |  |  | 90.25% - 94.51% |
Expected term |  |  | 5 - 7 Years |  |  |  | 5 - 7 Years |
Risk-free interest rate |  |  | 3.63% - 4.48% |  |  |  | 3.55% - 4.47% |
Weighted-average FV |  |  | $4.02 |  |  |  | $5.93 |
Schedule of option activity |
Schedule of option activity |  |  |  |  |  |  |  |  |  |  |
|  |  |  |  | Weighted |  |  | Weighted |  | Aggregate |
|  |  |  |  | Average |  |  | Average |  | Intrinsic |
|  | Number of |  |  | Exercise |  |  | Remaining |  | Value |
|  | Options |  |  | Price |  |  | Contractual Life |  | (in thousands) |
Outstanding at December 31, 2022 |  |  | 336,758 |  |  | $ | 12.54 |  |  |  |  |  |  |
Granted |  |  | 169,800 |  |  |  | 7.54 |  |  |  |  |  |  |
Forfeited |  |  | (24,700 | ) |  |  | 19.70 |  |  |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 481,858 |  |  | $ | 10.41 |  |  | 7.25 Years |  | $ | 350 |
Exercisable at December 31, 2023 |  |  | 151,310 |  |  | $ | 5.55 |  |  | 7.18 Years |  | $ | 233 |
Granted |  |  | 358,700 |  |  |  | 5.13 |  |  |  |  |  |  |
Forfeited |  |  | 177,554 |  |  |  | 9.92 |  |  |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 663,004 |  |  | $ | 6.69 |  |  | 7.75 Years |  | $ | – |
Exercisable at December 31, 2024 |  |  | 384,755 |  |  | $ | 8.63 |  |  | 6.65 Years |  | $ | – |
STOCKHOLDERS' EQUITY (Details - Schedule of RSU activity) |
Schedule of RSU activity |  |  |  |  |  |
|  | Shares |  |  | Weighted Average Grant Date Fair Value |
Unvested at beginning of 2024 |  | 71 |  |  | $ | 13.05 |
Granted |  | – |  |  |  | – |
Vested |  | (36 | ) |  | $ | 7.25 |
Forfeited |  | – |  |  |  | – |
Unvested at end of 2024 |  | 36 |  |  | $ | 13.05 |
Schedule of RSU activity |
Schedule of RSU activity |  | Shares |  |  | Weighted Average Grant Date Fair Value |
Unvested at beginning of 2024 |  | 143 |  |  | $ | 13.05 |
Granted |  | 45 |  |  | $ | 13.05 |
Vested |  | (187 | ) |  | $ | 7.25 |
Forfeited |  | – |  |  |  | – |
Unvested at end of 2024 |  | – |  |  |  | – |
Schedule of restricted stock awards |
Schedule of restricted stock awards |  |  |  |  |  |
|  |  |  |  | Weighted- |
|  | Nonvested |  |  | Average Grant- |
|  | Shares |  |  | Date Fair Value |
Nonvested at December 31, 2022 |  | $ | 17,865 |  |  | $ | 14.11 |
Granted |  |  | 19,795 |  |  |  | 10.98 |
Vested |  |  | (31,022 | ) |  |  | 12.29 |
Forfeited |  |  | (5,400 | ) |  |  | 11.68 |
Nonvested at December 31, 2023 |  | $ | 1,238 |  |  | $ | 20.17 |
Granted |  |  | 80,645 |  |  |  | 6.20 |
Vested |  |  | (71,803 | ) |  |  | 6.44 |
Forfeited |  |  | (10,080 | ) |  |  | 6.20 |
Nonvested at December 31, 2024 |  | $ | – |  |  | $ | – |
Schedule of warrant outstanding |
Schedule of warrant outstanding |  |  |  |  |  |
|  | Number of Warrants |  |  | Weighted Average Exercise Price |
Outstanding at December 31, 2022 |  |  | 440,204 |  |  | $ | 6.30 |
Granted |  |  | 200,000 |  |  |  | 17.00 |
Exercised |  |  | (29,459 | ) |  |  | 6.30 |
Outstanding at December 31, 2023 |  |  | 610,745 |  |  | $ | 9.80 |
Granted |  |  | – |  |  |  | – |
Expired |  |  | (282,334 | ) |  |  | 6.40 |
Exercised |  |  | (128,411 | ) |  |  | 6.30 |
Outstanding at December 31, 2024 |  |  | 200,000 |  |  |  | 17.00 |
Exercisable at December 31, 2024 |  |  | 200,000 |  |  | $ | 17.00 |

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested performance-based units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedPerformanceBasedUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock units. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-1 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration